Contents
Summary
Ethylbenzodioxolylbutanamine (EBDB), also known as Ethyl-J, is a relatively lesser-known substance known for its entactogenic, stimulant, and psychedelic properties. It serves as the N-ethyl counterpart to benzodioxylbutanamine (BDB), often referred to as “J,” and the α-ethyl companion to methylenedioxymethamphetamine (MDEA), commonly known as “Eve.”
Alexander Shulgin first carried out the synthesis of EBDB. In his book PiHKAL, it is noted that the minimum effective dosage was 90 mg, while the duration of its effects remains unspecified. Within the tested dosage range in PiHKAL, EBDB demonstrated minimal to negligible results. However, when administered at higher doses, typically in the several hundred-milligram fields, it has been reported to induce euphoric effects similar to those of methylbenzodioxylbutanamine (MBDB), also known as “Eden” or “Methyl-J,” although these effects are milder and of shorter duration.
Currently, there is a need for more available data regarding the pharmacological properties, metabolism, and toxicity of EBDB.
| Identifiers | |
|---|---|
| CAS Number | 167394-39-0 |
| 3D model (JSmol) | Interactive image |
| ChemSpider | 8389996 |
| PubChemCID | 10214504 |
| UNII | 5Y22MYG54G |
| CompTox Dashboard(EPA) | DTXSID90436778 |
| SMILES | |
| Properties | |
|---|---|
| Chemical formula | C13H19NO2 |
| Molar mass | 221.300 g·mol−1 |
| Melting point | 176 to 177 °C (349 to 351 °F; 449 to 450 K) |
FAQ
1. What is 1,3-Benzodioxolyl-N-ethylbutanamine (EBDB)?
1,3-Benzodioxolyl-N-ethylbutanamine, or EBDB or Ethyl-J, has entactogenic, stimulant, and psychedelic properties. It is chemically related to compounds like benzodioxylbutanamine (BDB) and methylenedioxyethylamphetamine (MDEA).
2. Who first synthesized EBDB?
EBDB was first synthesized by Alexander Shulgin, a renowned chemist and researcher in psychoactive substances.
3. What are the effects of EBDB?
The effects of EBDB can vary depending on the dosage. At lower doses, it may produce minimal to no results. However, at higher doses, typically several hundred milligrams, users have reported experiencing mild and short-lasting euphoria similar to substances like methylbenzodioxylbutanamine (MBDB or “Eden”).
4. What is the recommended dosage for EBDB?
In Alexander Shulgin’s book PiHKAL, the minimum effective dosage of EBDB was listed as 90 mg. It’s essential to note that precise dosing and safety information for EBDB are limited.
5. Is EBDB safe to use?
Due to the limited available data on EBDB, its safety profile, long-term effects, and potential risks need to be better understood. It is crucial to exercise extreme caution and avoid using substances with uncertain safety profiles.
6. Is EBDB legal?
The legal status of EBDB varies by country and jurisdiction. It may be subject to regulations or restrictions in some areas. It is essential to check local drug laws and rules before considering the use or possession of EBDB.
7. Are there known side effects of EBDB?
Due to the lack of comprehensive research, specific side effects of EBDB are not well-documented. However, as with other psychoactive substances, potential side effects may include increased heart rate, blood pressure, and mood alterations.
Great post. I’m going through a few of these issues as well..